-
Signature
-
/s/ Aaron Saltz, attorney-in-fact
-
Stock symbol
-
MGNI
-
Transactions as of
-
Jul 3, 2025
-
Transactions value $
-
-$1,023,627
-
Form type
-
4
-
Date filed
-
7/8/2025, 05:20 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Soroca Adam Lee |
CHIEF PRODUCT OFFICER |
C/O MAGNITE, INC., 1250 BROADWAY, 15TH FLOOR, NEW YORK |
/s/ Aaron Saltz, attorney-in-fact |
2025-07-08 |
0001725125 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MGNI |
Common Stock |
Options Exercise |
$3.94 |
+2 |
+0% |
$1.97 |
401K |
Jul 3, 2025 |
Direct |
F1 |
| transaction |
MGNI |
Common Stock |
Options Exercise |
$41K |
+8.33K |
+2.08% |
$4.92 |
409K |
Jul 3, 2025 |
Direct |
F1 |
| transaction |
MGNI |
Common Stock |
Sale |
-$1.06M |
-42.6K |
-10.41% |
$25.00 |
367K |
Jul 3, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MGNI |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2 |
-100% |
$0.00 |
0 |
Jul 3, 2025 |
Common Stock |
2 |
$1.97 |
Direct |
F1, F2, F3 |
| transaction |
MGNI |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-8.33K |
-6.41% |
$0.00 |
122K |
Jul 3, 2025 |
Common Stock |
8.33K |
$4.92 |
Direct |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: